Results 201 to 210 of about 199,564 (290)

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Lung Ischemia-Reperfusion Injury in Lung Transplant Surgery: Where Do We Stand? [PDF]

Antioxidants (Basel)
Berzenji L, Hendriks JMH, Verleden SE, Yogeswaran SK, Wen W, Lauwers P, Verleden G, Paep R, Mertens P, Rodrigus I, Adriaensen D, Van Schil P.   +11 more
europepmc   +1 more source

Rosuvastatin relieves myocardial ischemia/reperfusion injury by upregulating PPAR‑γ and UCP2

, 2018
Ling Wang, Rong Lin, Langtao Guo, Meiman Hong   +3 more
openalex   +2 more sources

A contemporary simple risk score for prediction of severe acute kidney injury after heart transplantation

ESC Heart Failure, Volume 12, Issue 2, Page 1166-1175, April 2025.
A contemporary simple risk score for prediction of severe AKI after HT. Abstract Background The aim of this study was to develop a simple risk score to estimate severe acute kidney injury (AKI) risk based on a large contemporary heart transplantation (HT) cohort.
Shuangshuang Zhu, Weihua Qiao, Yixuan Wang, Ying Zhou, Yin Xu, Shijie Wang, Tian Xia, Guohua Wang, Si Chen, Jiawei Shi, Nianguo Dong   +10 more
wiley   +1 more source

Efficacy of Batroxobin on Ischemia-Reperfusion Injury in Epigastric Artery Island Flaps in Rats. [PDF]

Plast Reconstr Surg Glob Open
Imagawa K, Masuda H, Morita D, Otsuka S, Akamatsu T.   +4 more
europepmc   +1 more source

Purinergic signaling by TCRαβ+ double-negative T regulatory cells ameliorates liver ischemia–reperfusion injury

Hua Jin, Mingyang Li, Xiyu Wang, Lu Yang, Xinjie Zhong, Zihan Zhang, Xiaotong Han, Jingjing Zhu, Mengyi Li, Songlin Wang, Simon C. Robson, Guangyong Sun, Dong Zhang   +12 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Cardiopulmonary bypass-mediated lung ischemia-reperfusion injury: A protective role of sitaxentan. [PDF]

J Int Med Res
Wang Z, Zhan R, Mo L, Zhang Y, Chen Y, Liu L, Bai Y.   +6 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

[Retracted] Curculigoside attenuates myocardial ischemia‑reperfusion injury by inhibiting the opening of the mitochondrial permeability transition pore. [PDF]

Int J Mol Med
Zhao Y, Guo Y, Chen Y, Liu S, Wu N, Jia D.   +5 more
europepmc   +1 more source